Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy

PURPOSE: To provide new information on adverse health outcomes (AHOs) in testicular cancer survivors (TCSs) after four cycles of etoposide and cisplatin (EPX4) or three or four cycles of bleomycin, etoposide, cisplatin (BEPX3/BEPX4). METHODS: Nine hundred fifty-two TCSs > 1 year postchemotherapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Fung, Chunkit, Sesso, Howard D., Williams, Annalynn M., Kerns, Sarah L., Monahan, Patrick, Abu Zaid, Mohammad, Feldman, Darren R., Hamilton, Robert J., Vaughn, David J., Beard, Clair J., Kollmannsberger, Christian K., Cook, Ryan, Althouse, Sandra, Ardeshir-Rouhani-Fard, Shirin, Lipshultz, Steve E., Einhorn, Lawrence H., Fossa, Sophie D., Travis, Lois B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455601/
https://ncbi.nlm.nih.gov/pubmed/28240972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.70.3108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados